GlassScriptPhysician profile
Rikin H Tank
NPI 1891105177
$3,678.40
in general payments reported to CMS, 2019-2025
20 companies · $1,259 in 2025
The $1,259 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,048 · 2024: $1,371 · 2025: $1,259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,668 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,667.55 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $627.02 | 2023-2025 | Impella |
| Amgen INC. | $559.21 | 2023-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $485.24 | 2023-2025 | Verquvo, Winrevair |
| Boston Scientific Corporation | $443.92 | 2023-2025 | Emblem Mri S-Icd, Bodyguardian, Watchman Access System |
| Pfizer INC. | $284.67 | 2024-2025 | |
| Esperion Therapeutics, INC. | $212.99 | 2024-2025 | Nexletol, Nexlizet |
| Abbott Laboratories | $208.82 | 2023-2025 | Mitraclip, Perclose Prostyle, Amplatzer Talisman |
| Alnylam Pharmaceuticals INC. | $171.49 | 2023-2025 | Amvuttra, Onpattro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.04 | 2023-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $114.13 | 2023-2025 | Eliquis, Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $100.08 | 2025 | |
| Edwards Lifesciences Corporation | $91.84 | 2024-2025 | Sapien 3 Ultra Resilia |
| Astrazeneca Pharmaceuticals LP | $66.19 | 2023-2025 | Farxiga, Wainua |
| Irhythm Technologies, INC. | $39.41 | 2024 | Zio Xt Patch, Zio Monitor |
| Medtronic, INC. | $30.33 | 2024 | Corevalve Evolut R |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.24 | 2024 | Lifevest |
| Heartflow, INC. | $17.68 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $17.28 | 2023 | Arcalyst |
| Scpharmaceuticals INC. | $17.13 | 2024 | |
| Cardiva Medical, INC. | $16.69 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rikin Tank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.